French pharmacy
Pierre Fabre Dermatologie Transvercid 12 mm in our organic pharmacy, Comment on advice for use and dosage with our partner Avis checked after your purchase.
Transvercid 12 mm 8 Dressings Warts Treatment Ducray is indicated for the local treatment of common warts , in particular multiple and / or large warts (including plantar warts ).
Due to its corrosive action, salicylic acid is one of the most common anti-wart products. Salicylic acid softens the wart , causing the shedding of superficial cells infected with human papillomavirus (HPV). Even in daily application, this method is relatively slow. It may take several weeks for it to give a result, and two to three months before the wart is completely gone .
In the evening before bedtime, after soaking it in lukewarm water, lightly rub the wart with a soft file, then clean it with lukewarm water and soap.
Open the bag on one side and across the entire width. Spread the edges, gently pull the transparent tab to the first device, peel it off and apply it to the wart.
Comment on the recommendations for use and dosage of Pierre Fabre Dermatologie Transvercid 12 mm 8 dressings with our partner Avis checked after your purchase.
The active substance is : salicylic acid 14.54 mg.
For a 12 mm device.
The other ingredients are : sterculia gum, propylene glycol, macrogol 300, N-3-chloroallyl chloride, hexaminium (quaternium 15).
This product comes in a box containing 8 devices and 10 plasters.
Most people find warts disgusting due to the fact that they are associated with dirt, lack of cleanliness, and poor maintenance of personal hygiene. Nevertheless, warts usually occur in people with low immunity, excessive hand sweating and or after stress, vegetative neurosis or acrocyanosis.
Causes
It is believed that 70 distinct strains of HPV can cause warts. These viruses exist naturally on the skin, so when a person's immune system is weakened (eg by a condition or drugs) they are at greater risk of contracting the virus. A simple cut is enough for the virus to infiltrate the body and cause the appearance of common, plantar or flat warts. Avoid walking with bare feet in public places, as this is a habit that puts you at risk of getting warts. Genital warts are a variety of warts that pose a more serious problem, especially since they are the most contagious. They are spread through direct sexual contact and it can take months to 1 month for them to appear.
Pharmacovigilance Report an adverse drug reaction(s)
ANSM - Updated: 04/10/2016
TRANSVERCID 14.54 mg / 12 mm, device for cutaneous application
Salicylic acid
Read this leaflet carefully before using this medicine. It contains important information for your treatment.
If you have further questions, if you are not sure, ask your doctor or pharmacist for more information.
· Keep this leaflet, you may need to read it again.
· If you need more information and advice, talk to your pharmacist.
· If the symptoms get worse or persist, consult a doctor.
· If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this notice :
1. WHAT IS TRANSVERCID 14.54 mg / 12 mm, Device for Cutaneous Application AND WHAT IT IS USED FOR?
2. BEFORE YOU USE TRANSVERCID 14.54 mg / 12 mm, device for cutaneous application?
3. HOW TO USE TRANSVERCID 14.54 mg / 12 mm, device for cutaneous application?
4. WHAT ARE THE POSSIBLE SIDE EFFECTS?
5. HOW TO STORE TRANSVERCID 14.54 mg / 12 mm, device for cutaneous application?
6. ADDITIONAL INFORMATION
1. WHAT IS TRANSVERCID 14.54 mg / 12 mm, Device for Cutaneous Application AND WHAT IT IS USED FOR?
Keratolytic.
(D. Dermatology)
This medicine is indicated in the local treatment of common warts including multiple warts and / or large (including plantar warts).
2. BEFORE YOU USE TRANSVERCID 14.54 mg / 12 mm, device for cutaneous application?
List of information needed before taking the medication
Not applicable.
Never use TRANSVERCID 14,54 mg / 12 mm, device for skin application in the following cases:
· allergy to one of the components.
IN CASE OF DOUBT, IT IS ESSENTIAL TO ASK THE ADVICE OF YOUR DOCTOR OR PHARMACIST.
Precautions for use; special warnings
Take special care with TRANSVERCID 14,54 mg / 12 mm, device for cutaneous application:
Precautions for use
In case of arteritis, diabetes or neuropathy, consult your doctor.
In case of failure after one month of treatment or in case of recurrence, the action to be taken must be reassessed by a doctor.
Avoid contact of the device with healthy skin and / or mucous membranes.
In case of pain, irritation, ulceration, bleeding, treatment should be discontinued.
Do not use the product on moles, wine stains, anogenital warts.
IF IN DOUBT, DO NOT HESITATE TO ASK YOUR DOCTOR OR PHARMACIST FOR ADVICE.
NEVER LEAVE THE REACH OF CHILDREN.
Taking other medicines
If you are taking or have recently taken any other medicines, including medicines obtained without a prescription, tell your doctor or pharmacist.
Interactions with food and drinks
Not applicable.
Interactions with herbal products or alternative therapies
Not applicable.
Use during pregnancy and lactation
Pregnancy and breast feeding
This medication should be used with caution during pregnancy and lactation.
In general, you should ask your doctor or pharmacist for advice before taking any medicine.
Not applicable.
Effects on ability to drive or use machines
Not applicable.
List of excipients with known effect
Not applicable.
3. HOW TO USE TRANSVERCID 14.54 mg / 12 mm, device for cutaneous application?
Not applicable.
Dosage
External use.
In the evening before bedtime, after soaking in warm water, lightly rub the wart with a soft lime, then clean with warm water and soap.
Open the bag on one side and across the width. Spread the edges, gently pull the transparent tab to the first device, peel it off and apply it to the wart. The portion in contact with the transparent support tab is applied to the skin and the blue protective film appears on the upper part of the device.
Hold the device in place using one of the adhesive strips attached to the packaging; finally let the device work all night (at least 8 hours) and remove it in the morning.
Repeat the operation each night with a new device until the wart disappears but not more than one month of treatment.
Method and route of administration
DERMAL
Frequency of administration
Once a day, preferably at bedtime.
Duration of treatment
Do not exceed one month of treatment. If the wart persists, consult your doctor.
Symptoms and instructions in case of overdose
If you have used more TRANSVERCID 14,54 mg / 12 mm, device for skin application than you should have:
Risk of burns in case of overdose.
Instructions for omitting one or more doses
Not applicable.
Not applicable.
4. WHAT ARE THE POSSIBLE SIDE EFFECTS?
Description of adverse effects
Like all medicines, this medicine can cause side effects, although not everybody gets them:
· local irritation of the skin around the treated wart, ulceration, bleeding, you must inform your doctor.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This also applies to any side effects not mentioned in this leaflet. You can also report side effects directly via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr
By reporting side effects, you can help provide more information about the safety of the medicine .
5. HOW TO STORE TRANSVERCID 14.54 mg / 12 mm, device for cutaneous application?
Keep out of the reach and sight of children.
Do not use TRANSVERCID 14.54 mg / 12 mm, device for skin application after the expiry date which is stated on the outer carton.
Store at a temperature not exceeding 25 ° C.
If necessary, warn against some visible signs of deterioration
Medicines should not be thrown away with sewage or garbage. Ask your pharmacist what to do with unused medications. These measures will help protect the environment.
Complete list of active substances and excipients
What does TRANSVERCID 14.54 mg / 12 mm contain, device for cutaneous application?
The active substance is:
Salicylic acid ................................................ .................................................. ......................... 14.54 mg
For a 12 mm device.
The other components are:
Gum of sterculia, propylene glycol, macrogol 300, N- (3-chloroallyl) hexaminium chloride (QUATERNIUM 15).
Non-removable protective film in high density polyethylene, colored blue.
Removable protective polyester support (MYLAR).
Adhesive plaster in low density polyethylene acrylic adhesive.
Pharmaceutical form and content
What is TRANSVERCID 14.54 mg / 12 mm, device for skin application and contents of the pack?
This medicine is in the form of a device for cutaneous application. Box of 8 or 16 devices.
DUCRAY DERMATOLOGICAL LABORATORIES
45, PLACE ABEL GANCE
92100 BOULOGNE
LABORATORIES PIERRE FABRE MEDICAMENT
45, PLACE ABEL GANCE
92100 BOULOGNE
PIERRE FABRE MEDICAMENT PRODUCTION
45, PLACE ABEL GANCE
92100 BOULOGNE
Names of the drug in the member states of the European Economic Area
Not applicable.
Date of approval of the notice
The last date this notice was approved is {date}.
AMM under exceptional circumstances
Not applicable.
Detailed information on this medicine is available on the Afssaps (France) website.
Information reserved for health professionals
Not applicable.
Not applicable.
Verrucide
salicylic acid
. Presentations . Composition . Indications . Contraindications . Attention . Pregnancy and breastfeeding . Instructions for use and dosage . Tips . Side effects . Lexicon
TRANSVERCID 3.62 mg / 6 mm: device for cutaneous application; box of 10, in sachets + 10 plasters.
Not refunded - Free price -
TRANSVERCID 14.54 mg / 12 mm: Device for cutaneous application; box of 8, in sachets + 10 plasters.
Not refunded - Free price -
Pierre Fabre Laboratory Drug
| p device | p device | |
| Salicylic acid | 3.62 mg | 14.54 mg |
A wart is a small benign skin tumor that can develop on almost any part of the body, mainly on the hands: common warts, under the feet - plantar warts, on the genitals and the face. We now know that they have a viral origin (more than 70 different viruses generally belonging to the family of HPV or human papillomavirus…
Read the article on the blog
